InfraReDx has developed a near infrared spectroscopy (NIRS) system to identify plaque composition. U. S. Food and Drug Administration (FDA) recently issued a clearance for the company’s 510(k) application to market its near infrared spectroscopic system for examining coronary arteries.
[ more ]
No comments:
Post a Comment